These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
53 related articles for article (PubMed ID: 6473627)
1. Methods for selecting items in a tardive dyskinesia rating scale. Sprague RL; White DM; Ullmann R; Kalachnik JE Psychopharmacol Bull; 1984; 20(3):339-45. PubMed ID: 6473627 [No Abstract] [Full Text] [Related]
2. Psychometric properties of the Dyskinesia Identification System: Condensed User Scale (DISCUS). Sprague RL; Kalachnik JE; Slaw KM Ment Retard; 1989 Jun; 27(3):141-8. PubMed ID: 2739567 [TBL] [Abstract][Full Text] [Related]
3. Tardive dyskinesia, the involuntary movement disorder that no one really understands. Jewell JA; Chemij M Can Nurse; 1983 Jun; 79(6):20-4. PubMed ID: 6552925 [No Abstract] [Full Text] [Related]
4. The convergent and divergent validity of the Matson Evaluation of Drug Side-effects (MEDS) and the Dyskinesia Identification System: Condensed User Scale (DISCUS). Matson JL; Fodstad JC; Rivet TT J Intellect Dev Disabil; 2008 Dec; 33(4):337-44. PubMed ID: 19039694 [TBL] [Abstract][Full Text] [Related]
5. Measurement of side effects including tardive dyskinesia. Campbell M; Palij M Psychopharmacol Bull; 1985; 21(4):1063-80. PubMed ID: 4089101 [No Abstract] [Full Text] [Related]
7. The dyskinesia identification system--Coldwater (DIS-Co): a tardive dyskinesia rating scale for the developmentally disabled. Sprague RL; Kalachnik JE; Breuning SE; Davis VJ; Ullmann RK; Cullari S; Davidson NA; Ferguson DG; Hoffner BA Psychopharmacol Bull; 1984; 20(2):328-38. PubMed ID: 6728999 [No Abstract] [Full Text] [Related]
8. [Tardive dyskinesia. AIMS (Abnormal Involuntary Movement Scale) as a diagnostic and research tool]. Burti L; Parolin A; Zanotelli R Minerva Med; 1981 Oct; 72(42):2829-36. PubMed ID: 7312199 [TBL] [Abstract][Full Text] [Related]
9. Buspirone in the treatment of tardive dyskinesia. Moss LE; Neppe VM; Drevets WC J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622 [TBL] [Abstract][Full Text] [Related]
10. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study. Bai YM; Yu SC; Lin CC J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949 [TBL] [Abstract][Full Text] [Related]
11. Number of nonassessable items and Cooperation level of the retarded during systematic dyskinesia examinations. Kalachnik JE; Kidd-Nielsen P; Harder SR Psychopharmacol Bull; 1983; 19(1):16-9. PubMed ID: 6828620 [No Abstract] [Full Text] [Related]
12. Tardive dyskinesia: recognition, management, and prevention. Crews EL Ala J Med Sci; 1980 Apr; 17(2):165-8. PubMed ID: 7416430 [No Abstract] [Full Text] [Related]
13. Observations in tardive dyskinesia. Mehta D; Eaton J; Burch M; Mehta S J Clin Psychiatry; 1985 Feb; 46(2):73. PubMed ID: 3968051 [No Abstract] [Full Text] [Related]
14. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial. Lee JG; Shin BS; Lee YC; Park SW; Kim YH Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029 [TBL] [Abstract][Full Text] [Related]
15. Yi-gan san for the treatment of neuroleptic-induced tardive dyskinesia: an open-label study. Miyaoka T; Furuya M; Yasuda H; Hayashida M; Nishida A; Inagaki T; Horiguchi J Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):761-4. PubMed ID: 18201810 [TBL] [Abstract][Full Text] [Related]
16. The dyskinesia Identification System Condensed User Scale (DISCUS): reliability, validity, and a total score cut-off for mentally ill and mentally retarded populations. Kalachnik JE; Sprague RL J Clin Psychol; 1993 Mar; 49(2):177-89. PubMed ID: 8098048 [TBL] [Abstract][Full Text] [Related]